| Visualizaciones | |
|---|---|
| Preparation and in vitro evaluation of 177Lu-iPSMA-RGD as a new heterobivalent radiopharmaceutical | 436 |
| agosto 2025 | septiembre 2025 | octubre 2025 | noviembre 2025 | diciembre 2025 | enero 2026 | febrero 2026 | |
|---|---|---|---|---|---|---|---|
| Preparation and in vitro evaluation of 177Lu-iPSMA-RGD as a new heterobivalent radiopharmaceutical | 0 | 2 | 2 | 5 | 1 | 10 | 0 |
| Visualizaciones | |
|---|---|
| 34-2017 Journal of Radioanalytical and Nuclear Chemistry-Alondra-1.pdf | 423 |
| Visualizaciones | |
|---|---|
| Estados Unidos | 168 |
| México | 56 |
| Alemania | 52 |
| Canadá | 30 |
| China | 19 |
| Rusia | 11 |
| Austria | 10 |
| Ucrania | 9 |
| India | 3 |
| Suecia | 3 |
| Visualizaciones | |
|---|---|
| Kiez | 49 |
| Ottawa | 26 |
| Woodbridge | 24 |
| Fairfield | 19 |
| Houston | 14 |
| Cambridge | 12 |
| Dearborn | 11 |
| Jacksonville | 11 |
| Mexico | 10 |
| Vienna | 10 |